Ramucirumab in Combination with Pembrolizumab in Treatment-Naïve Advanced Gastric or GEJ Adenocarcinoma: Safety and Antitumor Activity from the Phase 1a/b JVDF Trial
- DOI
- 10.3390/cancers12102985
- Published
- 2020-10-15
- Container
- Cancers
- Publisher
- MDPI AG
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.3390/cancers12102985,
title = {Ramucirumab in Combination with Pembrolizumab in Treatment-Naïve Advanced Gastric or GEJ Adenocarcinoma: Safety and Antitumor Activity from the Phase 1a/b JVDF Trial},
author = {Ian Chau and Nicolas Penel and Andres O. Soriano and Hendrik-Tobias Arkenau and Jennifer Cultrera and Rafael Santana-Davila and Emiliano Calvo and Christophe Le Tourneau and Lars Zender and Johanna C. Bendell and Gu Mi and Ling Gao and Samuel Clark McNeely and Joana M. Oliveira and David Ferry and Roy S. Herbst and Charles S. Fuchs},
year = {2020},
journal = {Cancers},
doi = {10.3390/cancers12102985},
url = {https://doi.org/10.3390/cancers12102985}
}RIS
TY - JOUR TI - Ramucirumab in Combination with Pembrolizumab in Treatment-Naïve Advanced Gastric or GEJ Adenocarcinoma: Safety and Antitumor Activity from the Phase 1a/b JVDF Trial AU - Ian Chau AU - Nicolas Penel AU - Andres O. Soriano AU - Hendrik-Tobias Arkenau AU - Jennifer Cultrera AU - Rafael Santana-Davila AU - Emiliano Calvo AU - Christophe Le Tourneau AU - Lars Zender AU - Johanna C. Bendell AU - Gu Mi AU - Ling Gao AU - Samuel Clark McNeely AU - Joana M. Oliveira AU - David Ferry AU - Roy S. Herbst AU - Charles S. Fuchs PY - 2020 JO - Cancers DO - 10.3390/cancers12102985 UR - https://doi.org/10.3390/cancers12102985 ER -
APA
Chau, I., Penel, N., Soriano, A. O., Arkenau, H., Cultrera, J., Santana-Davila, R., Calvo, E., Tourneau, C. L., Zender, L., Bendell, J. C., Mi, G., Gao, L., McNeely, S. C., Oliveira, J. M., Ferry, D., Herbst, R. S., & Fuchs, C. S. (2020). Ramucirumab in Combination with Pembrolizumab in Treatment-Naïve Advanced Gastric or GEJ Adenocarcinoma: Safety and Antitumor Activity from the Phase 1a/b JVDF Trial. Cancers. https://doi.org/10.3390/cancers12102985
Source records
- crossref · retrieved 2026-09-25T15:14:39.061Z